{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:49:14Z","timestamp":1790225354719,"version":"4.1.0"},"reference-count":133,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic inflammation is an important contributor to the development of cardiovascular disorders, and inflammasomes, especially the NOD-like receptor protein 3 (NLRP3), are emerging as crucial mediators in this context. Inflammasomes are activated through receptor-mediated danger signals, such as cholesterol crystals and cellular damage products, thereby stimulating the secretion of pro-inflammatory cytokines, which sustains inflammation. This mechanism drives atherosclerosis (via plaque formation and destabilization), heart failure (via fibrotic remodeling), and pericarditis (via exacerbation of pericardial inflammation). Therapeutic approaches seek to block inflammasome activation or their pro-inflammatory pathways. Colchicine, interleukin-1 inhibitors (anakinra, canakinumab), and Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors have a positive impact on cardiovascular inflammation. Various new compounds, such as MCC950, have been described as novel specific inhibitors of NLRP3. Further studies are needed to validate the effectiveness and safety of these treatments. Further elucidating the role of inflammasomes in cardiovascular disease could open the way to achieving more effective therapies, allowing for better management of high-risk cardiovascular patients.<\/jats:p>","DOI":"10.3390\/ijms26125439","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:02:03Z","timestamp":1749200523000},"page":"5439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-7072","authenticated-orcid":false,"given":"Mario","family":"Caldarelli","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8638-7565","authenticated-orcid":false,"given":"Laura","family":"Franza","sequence":"additional","affiliation":[{"name":"Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli-IRCCS of Rome, 00168 Rome, Italy"},{"name":"Emergency Department, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Cutrupi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Menegolo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"},{"name":"Emergency, Anesthesiological and Reanimation Sciences Department, Fondazione Policlinico Universitario A. Gemelli-IRCCS of Rome, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-1779","authenticated-orcid":false,"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gambassi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-8442","authenticated-orcid":false,"given":"Rossella","family":"Cianci","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Catholic University of Sacred Heart, 00168 Rome, Italy"},{"name":"Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","article-title":"Targeting the Inflammasome in Cardiovascular Disease","volume":"7","author":"Olsen","year":"2022","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of Assembly, Regulation and Signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-Induced Pyroptotic Cell Death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Arioz, B.I., Tarakcioglu, E., Olcum, M., and Genc, S. (2021). The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10071020"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1089\/ars.2014.5989","article-title":"The Inflammasome in Myocardial Injury and Cardiac Remodeling","volume":"22","author":"Toldo","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cophys.2017.10.005","article-title":"Mitochondria and Sterile Inflammation in the Heart","volume":"1","author":"Nakayama","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate Immune Pattern Recognition: A Cell Biological Perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and Regulation of the Inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/eji.201545839","article-title":"AIM2 Inflammasome in Infection, Cancer, and Autoimmunity: Role in DNA Sensing, Inflammation, and Innate Immunity","volume":"46","author":"Man","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ni.1864","article-title":"The AIM2 Inflammasome Is Essential for Host-Defense against Cytosolic Bacteria and DNA Viruses","volume":"11","author":"Rathinam","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41586-020-2174-3","article-title":"AIM2 Inflammasome Surveillance of DNA Damage Shapes Neurodevelopment","volume":"580","author":"Lammert","year":"2020","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/cvr\/cvu259","article-title":"Independent Roles of the Priming and the Triggering of the NLRP3 Inflammasome in the Heart","volume":"105","author":"Toldo","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 Inflammasome Activation during Myocardial Ischemia Reperfusion Is Cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1073\/pnas.1722041115","article-title":"Caspase-1 Inhibition Prevents Glial Inflammasome Activation and Pyroptosis in Models of Multiple Sclerosis","volume":"115","author":"McKenzie","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-Activated Gasdermin D Causes Pyroptosis by Forming Membrane Pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"ref_16","first-page":"2768","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 Inflammasome Is Released as a Particulate Danger Signal That Amplifies the Inflammatory Response","volume":"15","author":"Gomez","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3390\/cimb46080496","article-title":"Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications\u2014A Narrative Review","volume":"46","author":"Todor","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"156677","DOI":"10.1016\/j.cyto.2024.156677","article-title":"The ROS\/TXNIP\/NLRP3 Pathway Mediates LPS-Induced Microglial Inflammatory Response","volume":"181","author":"Zhao","year":"2024","journal-title":"Cytokine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1652244","DOI":"10.1155\/2022\/1652244","article-title":"Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS\/TXNIP\/NLRP3 Pathway to Prevent Inflammation","volume":"2022","author":"Luo","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_21","first-page":"244","article-title":"Inflammasomes in Cardiovascular Diseases","volume":"1","author":"Garg","year":"2011","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 Inflammasome in Acute Myocardial Infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1089\/ars.2014.5851","article-title":"Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease","volume":"21","author":"Cao","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent Advances in the Mechanisms of NLRP3 Inflammasome Activation and Its Inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 Targets Nod-like Receptor Protein 3 Inflammasome to Modulate Neuroinflammation in the Pathogenesis of Parkinson\u2019s Disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome Activation and Regulation: Toward a Better Understanding of Complex Mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"dmm050762","DOI":"10.1242\/dmm.050762","article-title":"The NLRP3 Inflammasome Is Essential for IL-18 Production in a Murine Model of Macrophage Activation Syndrome","volume":"17","author":"Gleeson","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13727","DOI":"10.1038\/ncomms13727","article-title":"The E3 Ubiquitin Ligase TRIM31 Attenuates NLRP3 Inflammasome Activation by Promoting Proteasomal Degradation of NLRP3","volume":"7","author":"Song","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 Inflammasome Assembly Is Regulated by Phosphorylation of the Pyrin Domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/thno.50281","article-title":"Oscillating lncRNA Platr4 Regulates NLRP3 Inflammasome to Ameliorate Nonalcoholic Steatohepatitis in Mice","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Aranda-Rivera, A.K., Srivastava, A., Cruz-Gregorio, A., Pedraza-Chaverri, J., Mulay, S.R., and Scholze, A. (2022). Involvement of Inflammasome Components in Kidney Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11020246"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vlachakis, P.K., Theofilis, P., Kachrimanidis, I., Giannakopoulos, K., Drakopoulou, M., Apostolos, A., Kordalis, A., Leontsinis, I., Tsioufis, K., and Tousoulis, D. (2024). The Role of Inflammasomes in Heart Failure. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105372"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3462530","DOI":"10.1155\/2019\/3462530","article-title":"ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.115.304437","article-title":"Moderate Hypoxia Potentiates Interleukin-1\u03b2 Production in Activated Human Macrophages","volume":"115","author":"Folco","year":"2014","journal-title":"Circ. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/micc.12259","article-title":"Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis","volume":"23","author":"Corliss","year":"2016","journal-title":"Microcirculation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI93025","article-title":"CD163+ Macrophages Promote Angiogenesis and Vascular Permeability Accompanied by Inflammation in Atherosclerosis","volume":"128","author":"Guo","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_38","first-page":"e626","article-title":"Mutual Inhibitory Mechanisms between PPAR\u03b3 and Hif-1\u03b1: Implication in Pulmonary Hypertension","volume":"2","author":"Yang","year":"2015","journal-title":"Recept. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hernandez-Quiles, M., Broekema, M.F., and Kalkhoven, E. (2021). PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.624112"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2017.07.021","article-title":"Anti-Inflammatory Mechanism of Galangin in Lipopolysaccharide-Stimulated Microglia: Critical Role of PPAR-\u03b3 Signaling Pathway","volume":"144","author":"Choi","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.mvr.2010.11.010","article-title":"HMGB1 Induces Human Lung Endothelial Cell Cytoskeletal Rearrangement and Barrier Disruption","volume":"81","author":"Wolfson","year":"2011","journal-title":"Microvasc. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1002\/jcb.27120","article-title":"Hypoxia Inducible Factor-1\u03b1\/Vascular Endothelial Growth Factor Signaling Activation Correlates with Response to Radiotherapy and Its Inhibition Reduces Hypoxia-Induced Angiogenesis in Lung Cancer","volume":"119","author":"Zhu","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1073\/pnas.1812947116","article-title":"Increased Gene Copy Number of DEFA1\/DEFA3 Worsens Sepsis by Inducing Endothelial Pyroptosis","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 Coordinates NLRP3 Inflammasome Activation by Facilitating Intracellular Nucleation of Soluble Ligands into Particulate Ligands in Sterile Inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1083\/jcb.201709057","article-title":"Trafficking of Cholesterol to the ER Is Required for NLRP3 Inflammasome Activation","volume":"217","author":"Roche","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 Inflamasomes Are Required for Atherogenesis and Activated by Cholesterol Crystals That Form Early in Disease","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 Inflammasome in Peripheral Blood Monocytes of Acute Coronary Syndrome Patients and Its Relationship with Statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_48","first-page":"14","article-title":"The Role of the NLRP3 Inflammasome in Atherosclerotic Disease","volume":"84","author":"Khair","year":"2024","journal-title":"Syst. Rev. Meta-Anal. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00380-015-0723-8","article-title":"Correlation of NLRP3 with Severity and Prognosis of Coronary Atherosclerosis in Acute Coronary Syndrome Patients","volume":"31","author":"Afrasyab","year":"2016","journal-title":"Heart Vessel."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","article-title":"Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis","volume":"24","author":"Shi","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.abg3067","article-title":"Olfactory Receptor 2 in Vascular Macrophages Drives Atherosclerosis by NLRP3-Dependent IL-1 Production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 Family in Innate Inflammation and Acquired Immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Borborema, M.E.d.A., Crovella, S., Oliveira, D., and Azev\u00eado Silva, J. (2020). Inflammasome Activation by NLRP1 and NLRC4 in Patients with Coronary Stenosis. Immunobiology, 225.","DOI":"10.1016\/j.imbio.2020.151940"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2016.06.193","article-title":"Elevated Levels of Triglycerides and Vldl-Cholesterol Provoke Activation of Nlrp1 Inflammasome in Endothelial Cells","volume":"220","author":"Bleda","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2013.12.201","article-title":"NLRP1 inflammasome, and not NLRP3, Is the Key in the Shift to Proinflammatory State on Endothelial Cells in Peripheral Arterial Disease","volume":"172","author":"Bleda","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.117.033098","article-title":"Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability","volume":"138","author":"Paulin","year":"2018","journal-title":"Circulation"},{"key":"ref_57","first-page":"2","article-title":"An Epidemic of Heart Failure? Recent Evidence from Europe","volume":"19","author":"Hoes","year":"1998","journal-title":"Eur. Heart J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e027852","DOI":"10.1161\/JAHA.122.027852","article-title":"Burden, Trends, and Inequalities of Heart Failure Globally, 1990 to 2019: A Secondary Analysis Based on the Global Burden of Disease 2019 Study","volume":"12","author":"Yan","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal Activation in Heart Failure with Reduced Ejection Fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute Heart Failure: Definition, Classification and Epidemiology","volume":"14","author":"Kurmani","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J. Card. Fail."},{"key":"ref_62","unstructured":"Golla, M.S.G., Hajouli, S., and Ludhwani, D. (2025). Heart Failure and Ejection Fraction. StatPearls, StatPearls Publishing."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart Failure with Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cianci, R., Franza, L., Borriello, R., Pagliari, D., Gasbarrini, A., and Gambassi, G. (2022). The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112712"},{"key":"ref_65","first-page":"2639","article-title":"AIM2-Driven Inflammasome Activation in Heart Failure","volume":"117","author":"Ruppert","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+\/Calmodulin-Dependent Protein Kinase II \u03b4 Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the Role of Inflammation in Heart Failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The Pathogenesis of Cardiac Fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Zeng, C., Duan, F., Hu, J., Luo, B., Huang, B., Lou, X., Sun, X., Li, H., Zhang, X., and Yin, S. (2020). NLRP3 Inflammasome-Mediated Pyroptosis Contributes to the Pathogenesis of Non-Ischemic Dilated Cardiomyopathy. Redox Biol., 34.","DOI":"10.1016\/j.redox.2020.101523"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCULATIONAHA.119.042336","article-title":"SNO-MLP (S-Nitrosylation of Muscle LIM Protein) Facilitates Myocardial Hypertrophy Through TLR3 (Toll-Like Receptor 3)-Mediated RIP3 (Receptor-Interacting Protein Kinase 3) and NLRP3 (NOD-Like Receptor Pyrin Domain Containing 3) Inflammasome Activation","volume":"141","author":"Tang","year":"2020","journal-title":"Circulation"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijcard.2013.12.137","article-title":"Formation of the Inflammasome in Acute Myocarditis","volume":"171","author":"Toldo","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Liao, Y., Liu, K., and Zhu, L. (2022). Emerging Roles of Inflammasomes in Cardiovascular Diseases. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.834289"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00109-018-1691-0","article-title":"NLRP3 Deficiency Accelerates Pressure Overload-Induced Cardiac Remodeling via Increased TLR4 Expression","volume":"96","author":"Li","year":"2018","journal-title":"J. Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/eurheartj\/ehy128","article-title":"Interleukin-1 Blockade in Cardiovascular Diseases: A Clinical Update","volume":"39","author":"Buckley","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 Cleavage Triggers Cardiac Inflammation and Fibrosis upon \u03b2-Adrenergic Insult","volume":"39","author":"Xiao","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory Signalling in Atrial Cardiomyocytes: A Novel Unifying Principle in Atrial Fibrillation Pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"He, S., Wang, Y., Yao, Y., Cao, Z., Yin, J., Zi, L., Chen, H., Fu, Y., Wang, X., and Zhao, Q. (2021). Inhibition of KCa3.1 Channels Suppresses Atrial Fibrillation via the Attenuation of Macrophage Pro-Inflammatory Polarization in a Canine Model with Prolonged Rapid Atrial Pacing. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.656631"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ehf2.13972","article-title":"Inflammasome Activation in End-Stage Heart Failure-Associated Atrial Fibrillation","volume":"9","author":"Kugler","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e012219","DOI":"10.1161\/JAHA.119.012219","article-title":"Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis","volume":"8","author":"Jin","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1152\/ajpheart.00372.2009","article-title":"Interleukin-1alpha Stimulates Proinflammatory Cytokine Expression in Human Cardiac Myofibroblasts","volume":"297","author":"Turner","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yjmcc.2025.02.011","article-title":"A Short History of the Atrial NLRP3 Inflammasome and Its Distinct Role in Atrial Fibrillation","volume":"202","author":"Poppenborg","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"111536","DOI":"10.1016\/j.intimp.2024.111536","article-title":"Inhibition of the P2X7 Receptor Prevents Atrial Proarrhythmic Remodeling in Experimental Post-Operative Atrial Fibrillation","volume":"129","author":"Ye","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10517-014-2578-x","article-title":"Effects of Interleukin-18 on Bioelectric Activity of Rat Atrial Cardiomyocytes under Normal Conditions and during Gradual Stretching of the Tissue","volume":"157","author":"Mitrokhin","year":"2014","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Podkowi\u0144ska, A., and Formanowicz, D. (2020). Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease. Antioxidants, 9.","DOI":"10.3390\/antiox9080752"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The Role of Inflammasomes in Kidney Disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Diaz-Ricart, M., Torramade-Moix, S., Pascual, G., Palomo, M., Moreno-Casta\u00f1o, A.B., Martinez-Sanchez, J., Vera, M., Cases, A., and Escolar, G. (2020). Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease. Toxins, 12.","DOI":"10.3390\/toxins12060361"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1742-1241.2009.02178.x","article-title":"Diagnostic Issues in the Clinical Management of Pericarditis","volume":"64","author":"Imazio","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"ref_89","unstructured":"Dababneh, E., and Siddique, M.S. (2024). Pericarditis. StatPearls, StatPearls Publishing."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11886-022-01710-8","article-title":"Acute Pericarditis: Update","volume":"24","author":"Lazarou","year":"2022","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e024931","DOI":"10.1161\/JAHA.121.024931","article-title":"Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients with Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center","volume":"11","author":"Peet","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/FJC.0000000000001553","article-title":"Novel Therapeutic Insights into the Treatment of Pericarditis: Targeting the Innate Immune System","volume":"83","author":"Bonaventura","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on Mechanisms of Action and Therapeutic Uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3899\/jrheum.2024-0683","article-title":"The Evaluation of Myocarditis in Patients with Still\u2019s Disease; Clinical Findings from the Multicentre International AIDA Network Still\u2019s Disease Registry","volume":"52","author":"Ruscitti","year":"2025","journal-title":"J. Rheumatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13075-018-1800-z","article-title":"Increased Neutrophil Extracellular Traps Activate NLRP3 and Inflammatory Macrophages in Adult-Onset Still\u2019s Disease","volume":"21","author":"Hu","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41584-023-01065-6","article-title":"Recent Advances and Evolving Concepts in Still\u2019s Disease","volume":"20","author":"Ruscitti","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40265-018-0956-9","article-title":"Adult-Onset Still\u2019s Disease: Molecular Pathophysiology and Therapeutic Advances","volume":"78","author":"Sfriso","year":"2018","journal-title":"Drugs"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Delplanque, M., Aouba, A., Hirsch, P., Fenaux, P., Graveleau, J., Malard, F., Roos-Weil, D., Belfeki, N., Drevon, L., and Oganesyan, A. (2021). USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still\u2019s Disease in Elderly Patients. J. Clin. Med., 10.","DOI":"10.3390\/jcm10235586"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40265-024-01993-x","article-title":"Adult-Onset Still\u2019s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options","volume":"84","author":"Bindoli","year":"2024","journal-title":"Drugs"},{"key":"ref_100","first-page":"489","article-title":"Association between HLA-DR B1 and Clinical Features of Adult Onset Still\u2019s Disease in Korea","volume":"21","author":"Song","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Castillo, R.L., Far\u00edas, J., Sandoval, C., Gonz\u00e1lez-Candia, A., Figueroa, E., Quezada, M., Cruz, G., Llanos, P., Jorquera, G., and Kostin, S. (2024). Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection?. Antioxidants, 13.","DOI":"10.3390\/antiox13111388"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Rroji, M., Spahia, N., Figurek, A., and Spasovski, G. (2025). Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation. Biomedicines, 13.","DOI":"10.3390\/biomedicines13030728"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Dabravolski, S.A., Zhuravlev, A.D., Kartuesov, A.G., Borisov, E.E., Sukhorukov, V.N., and Orekhov, A.N. (2022). Mitochondria-Mediated Cardiovascular Benefits of Sodium-Glucose Co-Transporter 2 Inhibitors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105371"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The Effect of Interleukin-1 Receptor Antagonist Therapy on Markers of Inflammation in Non-ST Elevation Acute Coronary Syndromes: The MRC-ILA Heart Study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e014941","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients with ST-Segment-Elevation Myocardial Infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/bi00852a043","article-title":"The Colchicine-Binding Protein of Mammalian Brain and Its Relation to Microtubules","volume":"7","author":"Weisenberg","year":"1968","journal-title":"Biochemistry"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2459\/JCM.0000000000001647","article-title":"Colchicine for the Treatment of the Spectrum of Cardiovascular Diseases: Current Evidence and Ongoing Perspectives","volume":"25","author":"Imazio","year":"2024","journal-title":"J. Cardiovasc. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e025266","DOI":"10.1161\/JAHA.122.025266","article-title":"Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2-Mediated Suppression of NLRP3 Inflammasome Activation","volume":"11","author":"Sun","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Tengesdal, I.W., Banks, M., Dinarello, C.A., and Marchetti, C. (2024). Screening NLRP3 Drug Candidates in Clinical Development: Lessons from Existing and Emerging Technologies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1422249"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.111.066365","article-title":"Treatment of Acute and Recurrent Idiopathic Pericarditis","volume":"127","author":"Lilly","year":"2013","journal-title":"Circulation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.001531","article-title":"Good Prognosis for Pericarditis with and Without Myocardial Involvement","volume":"128","author":"Imazio","year":"2013","journal-title":"Circulation"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J. Oxf. Acad."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/heartjnl-2014-306362","article-title":"Diagnosis and Treatment of Pericarditis","volume":"101","author":"Imazio","year":"2015","journal-title":"Heart"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2459\/JCM.0b013e3283340b97","article-title":"Medical Therapy of Pericardial Diseases: Part I: Idiopathic and Infectious Pericarditis","volume":"11","author":"Imazio","year":"2010","journal-title":"J. Cardiovasc. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40259-022-00537-7","article-title":"Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis","volume":"36","author":"Abadie","year":"2022","journal-title":"BioDrugs"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"113017","DOI":"10.1016\/j.intimp.2024.113017","article-title":"Recurrent Pericarditis and Interleukin (IL)-1 Inhibitors","volume":"141","author":"Principi","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2020.03.069","article-title":"Hydroxychloroquine for Colchicine-Resistant Glucocorticoid-Dependent Idiopathic Recurrent Pericarditis: A Pilot Observational Prospective Study","volume":"311","author":"Lazaros","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: A Literature Review","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Wang, M., Zhao, M., Yu, J., Xu, Y., Zhang, J., Liu, J., Zheng, Z., Ye, J., Wang, Z., and Ye, D. (2022). MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.727474"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin Is a Covalent NLRP3 Inhibitor with Strong Anti-Inflammasome Activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/ijmm.2023.5238","article-title":"Inhibitors of the NLRP3 Inflammasome Pathway as Promising Therapeutic Candidates for Inflammatory Diseases","volume":"51","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000658","article-title":"The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse","volume":"73","author":"Toldo","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e033881","DOI":"10.1161\/JAHA.123.033881","article-title":"Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic Mice","volume":"13","author":"Traughber","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/ATVBAHA.116.308916","article-title":"microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis","volume":"37","author":"Ouimet","year":"2017","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel Inhibitors of Cytokine-Induced IkappaBalpha Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-Inflammatory Effects in Vivo","volume":"272","author":"Pierce","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20160645","article-title":"BAY 11-7082 Inhibits the NF-\u03baB and NLRP3 Inflammasome Pathways and Protects against IMQ-Induced Psoriasis","volume":"131","author":"Irrera","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/jcmm.17104","article-title":"Immunoproteasome Modulates NLRP3 Inflammasome-Mediated Neuroinflammation under Cerebral Ischaemia and Reperfusion Conditions","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1536\/ihj.51.348","article-title":"BAY 11-7082, a Nuclear Factor-\u03baB Inhibitor, Reduces Inflammation and Apoptosis in a Rat Cardiac Ischemia-Reperfusion Injury Model","volume":"51","author":"Kim","year":"2010","journal-title":"Int. Heart J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.13292","article-title":"The Discovery of NLRP3 and Its Function in Cryopyrin-Associated Periodic Syndromes and Innate Immunity","volume":"322","author":"Putnam","year":"2024","journal-title":"Immunol. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:38Z","timestamp":1760032058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":133,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125439"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125439","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}